ERICH3: vesicular association and antidepressant treatment response

Selective serotonin reuptake inhibitors (SSRIs) are standard of care for major depressive disorder (MDD) pharmacotherapy, but only approximately half of these patients remit on SSRI therapy. Our previous genome-wide association study identified a single-nucleotide polymorphism (SNP) signal across th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular psychiatry Jg. 26; H. 6; S. 2415 - 2428
Hauptverfasser:	Liu, Duan, Zhuang, Yongxian, Zhang, Lingxin, Gao, Huanyao, Neavin, Drew, Carrillo-Roa, Tania, Wang, Yani, Yu, Jia, Qin, Sisi, Kim, Daniel C, Liu, Erica, Nguyen, Thanh Thanh Le, Biernacka, Joanna M, Kaddurah-Daouk, Rima, Dunlop, Boadie W, Craighead, W Edward, Mayberg, Helen S, Binder, Elisabeth B, Frye, Mark A, Wang, Liewei, Weinshilboum, Richard M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Nature Publishing Group 01.06.2021
Schlagworte:	Antidepressants Antidepressive Agents - therapeutic use Cell culture Central nervous system Clathrin Clinical trials Culture media Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Drug therapy Gene polymorphism Genome-wide association studies Genome-Wide Association Study Genomes Humans Immunofluorescence Isoforms Lysates Mental depression Patients Serotonin - therapeutic use Serotonin uptake inhibitors Serotonin Uptake Inhibitors - therapeutic use Single-nucleotide polymorphism Systematic review
ISSN:	1359-4184, 1476-5578, 1476-5578
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!